
In some new regions, an innovative drug of the original region was not zzso However, after the patent of the innovative drug is zzso a generic copy of the innovative drug from the original region was introduced and approved for marketing in the new zzso Another generic copy manufactured by the local sponsor of the new region is seeking for approval in the new zzso Despite unavailability of the innovative drug, the regulatory authority of the new region still wants to approve the local generic copy based on assessment of zzso between the local generic drug and the innovative zzso Following the bridging concept suggested by the zzso zzso guidance, we propose a method to evaluate average zzso between the generic copy of the new region and the innovative drug of the original region using the generic copy of the original region as the bridging reference zzso Sample size required by the zzso study in the new region is also zzso zzso examples illustrate the proposed zzso 

